Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KYNTRA BIO, INC. shareholders approved Election of Class III directors at the 2023-06-07 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
(i) Enrique Conterno: 67,436,799 shares of Common Stock voted for, 3,332,142 withheld, and 10,632,221 broker non-votes; (ii) Aoife Brennan, M.B., B.Ch.: 69,182,144 shares of Common Stock voted for, 1,586,797 withheld, and 10,632,221 broker non-votes; and (iii) Gerald Lema: 67,636,643 shares of Common Stock voted for, 3,132,298 withheld, and 10,632,221 broker non-votes.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KYNTRA BIO, INC. shareholders approved Advisory vote on executive compensation at the 2023-06-07 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
KYNTRA BIO, INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-07 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
78,505,537 shares of Common Stock voted for, 674,522 against, and 2,221,103 abstaining.
View on SEC.gov